These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1390958)

  • 1. Relationship Between Gonadal Hormone Levels and Symptom Severity in Female Patients With Schizophrenia.
    Sezer E; Köşger F; Altınöz AE; Yiğitaslan S
    Alpha Psychiatry; 2021 May; 22(3):130-135. PubMed ID: 36425447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Psychosis: Focus on Animal Models.
    Gogos A; van den Buuse M
    Curr Top Behav Neurosci; 2023; 62():133-163. PubMed ID: 35243605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroretinographic Abnormalities and Sex Differences Detected with Mesopic Adaptation in a Mouse Model of Schizophrenia: A and B Wave Analysis.
    Torres Jimenez N; Lines JW; Kueppers RB; Kofuji P; Wei H; Rankila A; Coyle JT; Miller RF; McLoon LK
    Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):16. PubMed ID: 32053730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Onset and Prodromal Stage to a Life-Long Course of Schizophrenia and Its Symptom Dimensions: How Sex, Age, and Other Risk Factors Influence Incidence and Course of Illness.
    Häfner H
    Psychiatry J; 2019; 2019():9804836. PubMed ID: 31139639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings.
    Gogos A; Sbisa AM; Sun J; Gibbons A; Udawela M; Dean B
    Int J Endocrinol; 2015; 2015():615356. PubMed ID: 26491441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpromazine versus placebo for schizophrenia.
    Adams CE; Awad GA; Rathbone J; Thornley B; Soares-Weiser K
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD000284. PubMed ID: 24395698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schizophrenia - a disorder in its own right?: results from 25 years of the ABC study].
    Häfner H; Maurer K; An der Heiden W
    Nervenarzt; 2013 Sep; 84(9):1093-4, 1096-103. PubMed ID: 23695002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classes of psychotic experiences in Kenyan children and adolescents.
    Mamah D; Owoso A; Mbwayo AW; Mutiso VN; Muriungi SK; Khasakhala LI; Barch DM; Ndetei DM
    Child Psychiatry Hum Dev; 2013 Jun; 44(3):452-9. PubMed ID: 23065300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of psychosis risk symptoms in Kenya.
    Mamah D; Mbwayo A; Mutiso V; Barch DM; Constantino JN; Nsofor T; Khasakhala L; Ndetei DM
    Compr Psychiatry; 2012 Jul; 53(5):516-24. PubMed ID: 21945193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of psychotic symptoms: in the city of Izmir, Turkey.
    Alptekin K; Ulas H; Akdede BB; Tümüklü M; Akvardar Y
    Soc Psychiatry Psychiatr Epidemiol; 2009 Nov; 44(11):905-10. PubMed ID: 19255702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex difference in age of onset of schizophrenia: findings from a community-based study in India.
    Venkatesh BK; Thirthalli J; Naveen MN; Kishorekumar KV; Arunachala U; Venkatasubramanian G; Subbakrishna DK; Gangadhar BN
    World Psychiatry; 2008 Oct; 7(3):173-6. PubMed ID: 18836543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation.
    Halbreich U
    CNS Drugs; 2007; 21(8):641-57. PubMed ID: 17630817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia.
    Odenwald M; Neuner F; Schauer M; Elbert T; Catani C; Lingenfelder B; Hinkel H; Häfner H; Rockstroh B
    BMC Med; 2005 Feb; 3():5. PubMed ID: 15707502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences.
    Häfner H; Riecher-Rössler A; Maurer K; Fätkenheuer B; Löffler W
    Eur Arch Psychiatry Clin Neurosci; 1992; 242(2-3):109-18. PubMed ID: 1486099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders.
    Hambrecht M; Maurer K; Häfner H; Sartorius N
    Eur Arch Psychiatry Clin Neurosci; 1992; 242(1):6-12. PubMed ID: 1390958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are sex differences in schizophrenia stable on a transnational basis?].
    Hambrecht M; Häfner H
    Schweiz Arch Neurol Psychiatr (1985); 1992; 143(6):525-40. PubMed ID: 1283031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in schizophrenia in three cultures. Results of the WHO collaborative study on psychiatric disability.
    Hambrecht M; Maurer K; Häfner H
    Soc Psychiatry Psychiatr Epidemiol; 1992 May; 27(3):117-21. PubMed ID: 1621135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization.
    Sartorius N; Gulbinat W; Harrison G; Laska E; Siegel C
    Soc Psychiatry Psychiatr Epidemiol; 1996 Sep; 31(5):249-58. PubMed ID: 8909114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of late-onset schizophrenia.
    Castle DJ; Murray RM
    Schizophr Bull; 1993; 19(4):691-700. PubMed ID: 8303220
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.